Jacqui Hall

Industry Experience

Contracts Manager

Novartis Pharmaceuticals Corporation

In-House Counsel

Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)

Jacqui’s experience in the biopharmaceutical and technology industries includes a variety of roles - both business and legal. Her experience is an asset when it comes to understanding clients’ business needs and developing pragmatic approaches to helping them.

Jacqui often assists clients with developing contracting processes and standardized agreement terms for various client relationships. She has extensive experience negotiating manufacturing and supply chain-related agreements (including for manufacture of biologics), SaaS and other software and technology-related agreements, clinical study agreements, the extensive range of agreements required for support of clinical trials including trials outside the U.S. and a range of agreements with academic and non-profit organizations including for transfer of materials and sponsored research.  

Jacqui’s clients include biopharmaceutical companies of many types and in various phases of life cycle: virtual and in discovery phase, companies with their first product launch, and clients with multiple products on the market.

experience +

experience –

Novartis Pharmaceuticals Corporation

Contracts Manager

  • Worked on clinical trial agreements
  • Helped develop guidance on negotiating clinical trial agreements

Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)

In-house Counsel

  • Handled a broad range of transactions including licensing of biotechnology and software technologies
  • Drafted a variety of consulting agreements, and service and manufacturing agreements

Recent Client Work +

Recent Client WOrk –

Industry Collaborations

  • Edimer Pharmaceuticals and CMC Biologics Manufacturing Contract to support the development of EDI200, a clinical-stage recombinant protein for the treatment of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disease with orphan designation in the USA and Europe
  • Evaluation Agreement for combination of client compound with other party’s proprietary delivery formulation
  • Services Agreement for a collection of human blood samples with certain specified infectious diseases for use by client in producing monoclonal antibodies

Customer Agreements

  • SaaS Agreement for access and use by client of cloud-based trial master file application for use in client’s worldwide clinical trials  
  • Agreement for management of client’s speaker bureau including facilitation of speaker training, payments to speakers and logistics
  • Agreement for consulting services such as PK analysis of client drug in combination with other drugs and to determine existence of drug-drug interaction

Academic Research

  • Short term Collaboration Agreement between nonprofit client and commercial organization for targeted drug design
  • Sponsored Research Agreement to explore the activity of client compound against CNS tumors with specified mutations in vitro and in vivo
  • Academic Research Agreement for sequencing of samples from tumor bank for specified mutations in patients with cancer, and description of baseline characteristics of the patient population

Clinical Trials

  • Supply Agreement for supply and distribution throughout the world of client’s clinical product in multiple studies
  • Multi-party Agreement for investigator-initiated study for which client provided product and commercial entity provided funding
  • Services Agreement for engagement of contract research organization for client’s clinical trial

Community +

Community –

Joe is or has been involved in a wide range of philanthropic and community organizations, including:

  • The Center for Discovery. Pro bono counsel for R&D initiatives at a leading provider of medical and clinical care and education services for people with complex developmental disabilities.
  • Dana-Farber Cancer Institute and Partners in Health. Pro bono counsel for an international health services joint venture.
  • Center for Maine Contemporary Art, Board of DirectorsTrustees.
  • Partners Healthcare Center for Personalized Genetic Medicine, Genetics Advisory Council, past member.
  • Columbia University’s College of Physicians and Surgeons, Medical Science and Technology Council, past member.
  • CAVU Foundation, Board of Directors, past member. CAVU  supported community programs that enhance the health care of underserved children in Massachusetts.
  • Venturing Out, Board of Directors, past member. Venturing Out was an innovative not-for-profit organization that taught entrepreneurship to incarcerated and court-involved adults and high-risk youth.
  • The Possible Project, Co-Founder of a not-for-profit that helps young people imagine, create and run their own business.
  • Slow Money, Maine and New York chapters. Joe worked with leadership to create pathways for individuals and families to provide financial assistance to farmers and agriculture businesses promoting sustainable local food systems. He also developed novel “patient loan” structures that have been used to raise critical financing for businesses that are re-building agricultural and fisheries food infrastructures.

Joe has spoken on business law and ethics at the Massachusetts Institute of Technology (Program of Health Sciences and Technology), Ross School of Business at the University of Michigan (Net Impact Conference), and Boston College Law School.

Joe was a member of the National Finance Council and actively involved in the voter protection team for the Stacey Abrams for Governor campaign.

Bar Admissions
  • Massachusetts
  • New York
  • ‍Suffolk University Law School, J.D., cum laude
  • ‍College of the Holy Cross, B.A.